Lv3
328 积分 2021-07-02 加入
Bispecific T cell engager therapy for refractory rheumatoid arthritis
7天前
已完结
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
7天前
已关闭
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
7天前
已完结
B-cell depletion in autoimmune diseases
7天前
已完结
Beyond ADCs: Harnessing Bispecific Antibodies to Directly Induce Apoptosis for Targeted Tumor Eradication
13天前
已关闭
Analysis of the relationship between primary tumor site and clinicopathological characteristics and survival prognosis of breast cancer patients based on SEER database
16天前
已完结
Radiotherapy and survival in breast cancer
17天前
已完结
Tumor Site and Breast Cancer Prognosis
18天前
已完结
Human OX40L–CAR-T regs target activated antigen-presenting cells and control T cell alloreactivity
26天前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
1个月前
已完结
皖公网安备34019202002308
